Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Multidrug resistance related molecules in human and murine lung.

Scheffer GL, Pijnenborg AC, Smit EF, Müller M, Postma DS, Timens W, van der Valk P, de Vries EG, Scheper RJ.

J Clin Pathol. 2002 May;55(5):332-9.

2.

MRP6 (ABCC6) detection in normal human tissues and tumors.

Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ.

Lab Invest. 2002 Apr;82(4):515-8. No abstract available.

PMID:
11950908
3.

Tissue distribution and induction of human multidrug resistant protein 3.

Scheffer GL, Kool M, de Haas M, de Vree JM, Pijnenborg AC, Bosman DK, Elferink RP, van der Valk P, Borst P, Scheper RJ.

Lab Invest. 2002 Feb;82(2):193-201.

PMID:
11850532
4.

Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.

van den Wijngaard RM, Asghar SS, Pijnenborg AC, Tigges AJ, Westerhof W, Das PK.

Br J Dermatol. 2002 Jan;146(1):80-7.

PMID:
11841370
5.

Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.

Schroeijers AB, Scheffer GL, Reurs AW, Pijnenborg AC, Abbondanza C, Wiemer EA, Scheper RJ.

J Histochem Cytochem. 2001 Nov;49(11):1379-85.

PMID:
11668191
6.

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH.

Cancer Res. 2001 Apr 15;61(8):3458-64.

7.

Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.

Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, van der Linden M, de Vree JM, van der Valk P, Elferink RP, Borst P, Scheper RJ.

Cancer Res. 2000 Sep 15;60(18):5269-77.

8.

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.

Scheffer GL, Maliepaard M, Pijnenborg AC, van Gastelen MA, de Jong MC, Schroeijers AB, van der Kolk DM, Allen JD, Ross DD, van der Valk P, Dalton WS, Schellens JH, Scheper RJ.

Cancer Res. 2000 May 15;60(10):2589-93.

Supplemental Content

Loading ...
Support Center